Items home
EnglishFrenchDutchSpanishGermanItalianChineseTurkishPolish

EQA Programmes

A sample list of molecular EQA programmes available from QCMD is displayed below. For further information or to register for any EQA programme please Login to your QCMD Participant Profile Area. If you do not have a Username and Password please click here.

Blood Borne Virus
Click to view / hide
B19 virus
Feature
Available Format(s)
Catalogue Number
QAV034116_1 QAV034116_2
Total Number of Challenges
1 2
Number of Panel Members
8 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
HBV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV124160_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HBV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV064118_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
HCV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV134167_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HCV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV034117_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
Hepatitis A virus
Feature
Available Format(s)
Catalogue Number
QAV124156_1 QAV124156_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 10 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Hepatitis B virus
Feature
Available Format(s)
Catalogue Number
QAV994110_1 QAV994110_2 QAV994110_4
Total Number of Challenges
1 2 4
Number of Panel Members
8 4 per challenge 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3 Q1,Q2,Q3 & Q4
Hepatitis C virus
Feature
Available Format(s)
Catalogue Number
QAV994112_1 QAV994112_2 QAV994112_4
Total Number of Challenges
1 2 4
Number of Panel Members
8 4 per challenge 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3 Q1,Q2,Q3 & Q4
Hepatitis D virus
Feature
Available Format(s)
Catalogue Number
QAV144170_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
Hepatitis E virus
Feature
Available Format(s)
Catalogue Number
QAV124157_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
HIV-1 (DNA)
Feature
Available Format(s)
Catalogue Number
QAV034114_1 QAV034114_2
Total Number of Challenges
1 2
Number of Panel Members
8 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
HIV-1 (RNA)
Feature
Available Format(s)
Catalogue Number
QAV994108_1 QAV994108_2 QAV994108_4
Total Number of Challenges
1 2 4
Number of Panel Members
8 4 per challenge 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3 Q1,Q2,Q3 & Q4
HIV-1 Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV024131_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HIV-1 Drug Resistance (Integrase)
Feature
Available Format(s)
Catalogue Number
QAV114146_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Central Nervous System
Click to view / hide
BK virus
Feature
Available Format(s)
Catalogue Number
QAV144166_1 QAV144166_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Borrelia burgdorferi spp. (Lyme Disease)
Feature
Available Format(s)
Catalogue Number
QAB114147_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Chikungunya virus
Feature
Available Format(s)
Catalogue Number
QAV154175_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Central Nervous System I (Viral)
Feature
Available Format(s)
Catalogue Number
QAV174195_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System II (Non-Viral)
Feature
Available Format(s)
Catalogue Number
QAM174196_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Dengue virus
Feature
Available Format(s)
Catalogue Number
QAV114148_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Enterovirus
Feature
Available Format(s)
Catalogue Number
QAV984104_1 QAV984104_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Enterovirus Typing
Feature
Available Format(s)
Catalogue Number
QAV164185_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q1
Herpes Simplex virus 1 & 2
Feature
Available Format(s)
Catalogue Number
QAV994105_1 QAV994105_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
JC virus
Feature
Available Format(s)
Catalogue Number
QAV074106_1 QAV074106_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Measles / Mumps
Feature
Available Format(s)
Catalogue Number
QAV144171_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Parechovirus
Feature
Available Format(s)
Catalogue Number
QAV114145_1 QAV114145_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Varicella-Zoster virus
Feature
Available Format(s)
Catalogue Number
QAV034103_1 QAV034103_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
West Nile virus
Feature
Available Format(s)
Catalogue Number
QAV104141_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Zika virus
Feature
Available Format(s)
Catalogue Number
QAV164186_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Congenital Infections
Click to view / hide
Cytomegalovirus Dried Blood Spots
Feature
Available Format(s)
Catalogue Number
QAV064127_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Drug Resistance
Click to view / hide
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Extended Spectrum ß-lactamase and Carbapenemase
Feature
Available Format(s)
Catalogue Number
QAB134162_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
HBV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV124160_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HCV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV134167_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
HIV-1 Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV024131_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HIV-1 Drug Resistance (Integrase)
Feature
Available Format(s)
Catalogue Number
QAV114146_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Methicillin Resistant Staphylococcus aureus
Feature
Available Format(s)
Catalogue Number
QAB064124_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Vancomycin Resistant Enterococci
Feature
Available Format(s)
Catalogue Number
QAB134163_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Exotic / Emerging Diseases
Click to view / hide
Chikungunya virus
Feature
Available Format(s)
Catalogue Number
QAV154175_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Dengue virus
Feature
Available Format(s)
Catalogue Number
QAV114148_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
MERS Coronavirus
Feature
Available Format(s)
Catalogue Number
QAV154181_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q2
West Nile virus
Feature
Available Format(s)
Catalogue Number
QAV104141_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Zika virus
Feature
Available Format(s)
Catalogue Number
QAV164186_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Gastrointestinal Diseases
Click to view / hide
Adenovirus
Feature
Available Format(s)
Catalogue Number
QAV054133_1 QAV054133_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Bacterial Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAB124153_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Clostridium difficile
Feature
Available Format(s)
Catalogue Number
QAB084125_1 QAB084125_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Diarrheagenic Escherichia coli
Feature
Available Format(s)
Catalogue Number
QAB154179_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Helicobacter pylori
Feature
Available Format(s)
Catalogue Number
QAB164190_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q3
Norovirus
Feature
Available Format(s)
Catalogue Number
QAV084139_1 QAV084139_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Parasitic Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAP124154_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Viral Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAV124152_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Immunocompromised Associated Diseases
Click to view / hide
Aspergillus spp.
Feature
Available Format(s)
Catalogue Number
QAF104140_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
BK virus
Feature
Available Format(s)
Catalogue Number
QAV144166_1 QAV144166_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Candida spp.
Feature
Available Format(s)
Catalogue Number
QAF124151_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Cytomegalovirus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV124150_1 QAV124150_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus
Feature
Available Format(s)
Catalogue Number
QAV024121_1 QAV024121_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV134161_1 QAV134161_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Cytomegalovirus
Feature
Available Format(s)
Catalogue Number
QAV014120_1 QAV014120_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Herpes virus 6
Feature
Available Format(s)
Catalogue Number
QAV084119_1 QAV084119_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Immunocompromised
Feature
Available Format(s)
Catalogue Number
QAM174197_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
JC virus
Feature
Available Format(s)
Catalogue Number
QAV074106_1 QAV074106_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Pneumocystis jirovecii pneumonia (PCP)
Feature
Available Format(s)
Catalogue Number
QAF114144_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4
Multiple Pathogen / Syndromic
Click to view / hide
Bacterial Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAB124153_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Chlamydia trachomatis and Neisseria gonorrhoeae
Feature
Available Format(s)
Catalogue Number
QAB174191_1 QAB174191_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Central Nervous System I (Viral)
Feature
Available Format(s)
Catalogue Number
QAV174195_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System II (Non-Viral)
Feature
Available Format(s)
Catalogue Number
QAM174196_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Immunocompromised
Feature
Available Format(s)
Catalogue Number
QAM174197_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Neonatal / New-born infections
Feature
Available Format(s)
Catalogue Number
QAM174199_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Parasitic Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAP124154_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Respiratory I
Feature
Available Format(s)
Catalogue Number
QAV164188_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory II
Feature
Available Format(s)
Catalogue Number
QAV164189_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory III
Feature
Available Format(s)
Catalogue Number
QAM174193_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sepsis
Feature
Available Format(s)
Catalogue Number
QAB164178_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections I
Feature
Available Format(s)
Catalogue Number
QAB154177_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections II
Feature
Available Format(s)
Catalogue Number
QAM174201_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Viral Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAV124152_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Respiratory Diseases
Click to view / hide
Adenovirus
Feature
Available Format(s)
Catalogue Number
QAV054133_1 QAV054133_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Bordetella pertussis
Feature
Available Format(s)
Catalogue Number
QAB094132_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Chlamydophila pneumoniae
Feature
Available Format(s)
Catalogue Number
QAB084107_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q2
Chlamydia psittaci
Feature
Available Format(s)
Catalogue Number
QAB134165_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q2
Coronavirus
Feature
Available Format(s)
Catalogue Number
QAV064137_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Human Metapneumovirus
Feature
Available Format(s)
Catalogue Number
QAV054135_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Influenza A & B virus
Feature
Available Format(s)
Catalogue Number
QAV054134_1 QAV054134_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Influenza Haemagglutinin Typing
Feature
Available Format(s)
Catalogue Number
QAV064138_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q4
Legionella pneumophila
Feature
Available Format(s)
Catalogue Number
QAB044122_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
Measles / Mumps
Feature
Available Format(s)
Catalogue Number
QAV144171_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
MERS Coronavirus
Feature
Available Format(s)
Catalogue Number
QAV154181_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q2
Mycobacterium tuberculosis
Feature
Available Format(s)
Catalogue Number
QAB014129_1 QAB014129_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Mycoplasma pneumoniae
Feature
Available Format(s)
Catalogue Number
QAB174192_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q2
Parainfluenza virus
Feature
Available Format(s)
Catalogue Number
QAV064136_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Pneumocystis jirovecii pneumonia (PCP)
Feature
Available Format(s)
Catalogue Number
QAF114144_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Respiratory Syncytial virus
Feature
Available Format(s)
Catalogue Number
QAV054142_1 QAV054142_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Rhinovirus
Feature
Available Format(s)
Catalogue Number
QAV064143_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory I
Feature
Available Format(s)
Catalogue Number
QAV164188_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory II
Feature
Available Format(s)
Catalogue Number
QAV164189_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory III
Feature
Available Format(s)
Catalogue Number
QAM174193_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Serology
Click to view / hide
Blood borne virus serology
Feature
Available Format(s)
Catalogue Number
QAS144172_2
Total Number of Challenges
2
Number of Panel Members
4 to 6 per challenge
Distribution / Testing Period
Q1 & Q3
Immune status serology
Feature
Available Format(s)
Catalogue Number
QAS144174_2
Total Number of Challenges
2
Number of Panel Members
4 to 6 per challenge
Distribution / Testing Period
Q1 & Q3
Viral hepatitis serology
Feature
Available Format(s)
Catalogue Number
QAS144173_2
Total Number of Challenges
2
Number of Panel Members
4 to 6 per challenge
Distribution / Testing Period
Q1 & Q3
Sexually Transmitted Infections
Click to view / hide
Chlamydia trachomatis
Feature
Available Format(s)
Catalogue Number
QAB004101_1 QAB004101_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Chlamydia trachomatis and Neisseria gonorrhoeae
Feature
Available Format(s)
Catalogue Number
QAB174191_1 QAB174191_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Herpes simplex virus 1 & 2
Feature
Available Format(s)
Catalogue Number
QAV994105_1 QAV994105_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
Human Papillomavirus (PreservCyt)
Feature
Available Format(s)
Catalogue Number
QAV094130_1 QAV094130_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Human Papillomavirus (SurePath)
Feature
Available Format(s)
Catalogue Number
QAV184204_1 QAV184204_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Mycoplasma genitalium
Feature
Available Format(s)
Catalogue Number
QAB184205_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q1
Neisseria gonorrhoeae
Feature
Available Format(s)
Catalogue Number
QAB034126_1 QAB034126_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Sexually Transmitted Infections I
Feature
Available Format(s)
Catalogue Number
QAB154177_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections II
Feature
Available Format(s)
Catalogue Number
QAM174201_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Syphilis
Feature
Available Format(s)
Catalogue Number
QAB154180_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q4
Trichomonas vaginalis
Feature
Available Format(s)
Catalogue Number
QAP184202_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q1
Transplant Associated Diseases
Click to view / hide
Adenovirus
Feature
Available Format(s)
Catalogue Number
QAV054133_1 QAV054133_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
BK virus
Feature
Available Format(s)
Catalogue Number
QAV144166_1 QAV144166_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Cytomegalovirus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV124150_1 QAV124150_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus
Feature
Available Format(s)
Catalogue Number
QAV024121_1 QAV024121_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV134161_1 QAV134161_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Cytomegalovirus
Feature
Available Format(s)
Catalogue Number
QAV014120_1 QAV014120_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Herpes virus 6
Feature
Available Format(s)
Catalogue Number
QAV084119_1 QAV084119_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
JC virus
Feature
Available Format(s)
Catalogue Number
QAV074106_1 QAV074106_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4
Typing
Click to view / hide
Bacterial 16S Ribosomal RNA
Feature
Available Format(s)
Catalogue Number
QAB164183_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q4
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Enterovirus Typing
Feature
Available Format(s)
Catalogue Number
QAV164185_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q1
HBV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV124160_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HBV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV064118_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
HCV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV134167_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HCV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV034117_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
HIV-1 Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV024131_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HIV-1 Drug Resistance (Integrase)
Feature
Available Format(s)
Catalogue Number
QAV114146_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Influenza Haemagglutinin Typing
Feature
Available Format(s)
Catalogue Number
QAV064138_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q4
MALDI-TOF
Feature
Available Format(s)
Catalogue Number
QAB124155_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Methicillin Resistant Staphylococcus aureus Typing (epidemiology and outbreak studies)
Feature
Available Format(s)
Catalogue Number
QAB074128_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Staphylococcus aureus spa
Feature
Available Format(s)
Catalogue Number
QAB134164_1
Total Number of Challenges
1
Number of Panel Members
6 to 12
Distribution / Testing Period
Q3
EQA Pilot Studies
Click to view / hide
Bacterial 16S Ribosomal RNA
Feature
Available Format(s)
Catalogue Number
QAB164183_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q4
Bacterial Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAB124153_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System I (Viral)
Feature
Available Format(s)
Catalogue Number
QAV174195_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System II (Non-Viral)
Feature
Available Format(s)
Catalogue Number
QAM174196_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Dermatophytosis
Feature
Available Format(s)
Catalogue Number
QAF164187_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
Diarrheagenic Escherichia coli
Feature
Available Format(s)
Catalogue Number
QAB154179_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Enterovirus Typing
Feature
Available Format(s)
Catalogue Number
QAV164185_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q1
Extended Spectrum ß-lactamase and Carbapenemase
Feature
Available Format(s)
Catalogue Number
QAB134162_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Group B Streptococcus
Feature
Available Format(s)
Catalogue Number
QAB174200_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Helicobacter pylori
Feature
Available Format(s)
Catalogue Number
QAB164190_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
Immunocompromised
Feature
Available Format(s)
Catalogue Number
QAM174197_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
MALDI-TOF
Feature
Available Format(s)
Catalogue Number
QAB124155_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Neonatal / New-born infections
Feature
Available Format(s)
Catalogue Number
QAM174199_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Parasitic Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAP124154_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Respiratory I
Feature
Available Format(s)
Catalogue Number
QAV164188_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory II
Feature
Available Format(s)
Catalogue Number
QAV164189_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory III
Feature
Available Format(s)
Catalogue Number
QAM174193_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sepsis
Feature
Available Format(s)
Catalogue Number
QAB164178_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections I
Feature
Available Format(s)
Catalogue Number
QAB154177_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections II
Feature
Available Format(s)
Catalogue Number
QAM174201_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Vancomycin Resistant Enterococci
Feature
Available Format(s)
Catalogue Number
QAB134163_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Viral Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAV124152_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Zika virus
Feature
Available Format(s)
Catalogue Number
QAV164186_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
New EQA Pilot Studies
Click to view / hide
Human Papillomavirus (SurePath)
Feature
Available Format(s)
Catalogue Number
QAV184204_1 QAV184204_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Mycoplasma genitalium
Feature
Available Format(s)
Catalogue Number
QAB184205_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q1
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4
Trichomonas vaginalis
Feature
Available Format(s)
Catalogue Number
QAP184202_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q1
Other
Click to view / hide
Dermatophytosis
Feature
Available Format(s)
Catalogue Number
QAF164187_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
Group B Streptococcus
Feature
Available Format(s)
Catalogue Number
QAB174200_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Mycoplasma spp. (cell contamination)
Feature
Available Format(s)
Catalogue Number
QAB144168_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4
Unit 5, Technology Terrace, Todd Campus, West of Scotland Science Park Glasgow G20 0XA Scotland, UK
Tel: +44 (0)141 945 6474 Fax: +44 (0)141 945 5795 Contact Us